TY - JOUR
T1 - Effect of Sucralfate on the Absorption and Pharmacokinetics of Chlorpropamide
AU - Letendre, Peter W.
AU - Carlson, James D.
AU - Seifert, Randall D.
AU - Dietz, Albert J.
AU - Dimmit, Dan
PY - 1986
Y1 - 1986
N2 - This study compared the pharmacokinetics of chlorpropamide (C) when administered alone, or in combination with sucralfate (S) to evaluate whether a drug‐drug interaction exists between these two agents in vivo. A two‐way, randomized, cross‐over study was performed in 12 healthy male volunteers who received 250 mg C alone or were pretreated with S qid for two days and then received a single 250‐mg dose of C with S on day 3 and continued to take sucralfate throughout the day while serial blood samples were drawn. High‐performance liquid chromatography determination of plasma concentrations found there to be no statistically significant differences in maximum concentration, time to maximum concentration, elimination rate constant, or area under the concentration‐time curve from 0 to 96 hours. However, there was a statistically significant difference in the area under the curve from 0 to infinity data (P < .05). The authors conclude that there appears to be no drug interaction between sucralfate and chlorpropamide when given concurrently; however, a trend towards less drug availability was seen that may warrant a future multiple‐dose study to further evaluate the significance of this finding. 1986 American College of Clinical Pharmacology
AB - This study compared the pharmacokinetics of chlorpropamide (C) when administered alone, or in combination with sucralfate (S) to evaluate whether a drug‐drug interaction exists between these two agents in vivo. A two‐way, randomized, cross‐over study was performed in 12 healthy male volunteers who received 250 mg C alone or were pretreated with S qid for two days and then received a single 250‐mg dose of C with S on day 3 and continued to take sucralfate throughout the day while serial blood samples were drawn. High‐performance liquid chromatography determination of plasma concentrations found there to be no statistically significant differences in maximum concentration, time to maximum concentration, elimination rate constant, or area under the concentration‐time curve from 0 to 96 hours. However, there was a statistically significant difference in the area under the curve from 0 to infinity data (P < .05). The authors conclude that there appears to be no drug interaction between sucralfate and chlorpropamide when given concurrently; however, a trend towards less drug availability was seen that may warrant a future multiple‐dose study to further evaluate the significance of this finding. 1986 American College of Clinical Pharmacology
UR - http://www.scopus.com/inward/record.url?scp=0023008116&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023008116&partnerID=8YFLogxK
U2 - 10.1002/j.1552-4604.1986.tb02960.x
DO - 10.1002/j.1552-4604.1986.tb02960.x
M3 - Article
C2 - 3793953
AN - SCOPUS:0023008116
SN - 0091-2700
VL - 26
SP - 622
EP - 625
JO - The Journal of Clinical Pharmacology
JF - The Journal of Clinical Pharmacology
IS - 8
ER -